FPR2 and cardiovascular disorder: Hong Shi and Brian H. Annex discuss the study by Margraf et al, in this issue of EMBO Mol Med, that investigates the interplay between inflammatory arthritis and cardiovascular disease, and provides a mechanistic basis for exploring FPR2-targeted therapies.